COSCIENS Biopharma, Inc. (CSCI.TO)
8.88
+0.13
(+1.49%)
CAD |
TSX |
Oct 05, 15:59
COSCIENS Biopharma Net Income (Quarterly) : -0.2796M for June 30, 2026
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -0.2796M |
| March 31, 2026 | -0.251M |
| December 31, 2025 | -3.044M |
| September 30, 2025 | -2.505M |
| June 30, 2025 | -3.149M |
| March 31, 2025 | -3.837M |
| December 31, 2024 | -9.413M |
| September 30, 2024 | -7.850M |
| June 30, 2024 | -1.946M |
| March 31, 2024 | -1.889M |
| December 31, 2023 | -2.131M |
| September 30, 2023 | -1.040M |
| June 30, 2023 | -1.155M |
| March 31, 2023 | -5.755M |
| December 31, 2022 | -16.90M |
| September 30, 2022 | -4.467M |
| June 30, 2022 | -5.383M |
| March 31, 2022 | -3.344M |
| December 31, 2021 | -3.648M |
| September 30, 2021 | -2.434M |
| June 30, 2021 | -2.561M |
| March 31, 2021 | -1.846M |
| December 31, 2020 | -1.708M |
| September 30, 2020 | -1.514M |
| June 30, 2020 | -4.780M |
| Date | Value |
|---|---|
| March 31, 2020 | 1.048M |
| December 31, 2019 | -1.328M |
| September 30, 2019 | -0.4371M |
| June 30, 2019 | 0.2756M |
| March 31, 2019 | -6.529M |
| December 31, 2018 | -6.770M |
| September 30, 2018 | -3.279M |
| June 30, 2018 | -3.360M |
| March 31, 2018 | 18.24M |
| December 31, 2017 | -0.6153M |
| September 30, 2017 | -12.07M |
| June 30, 2017 | -3.429M |
| March 31, 2017 | -5.467M |
| December 31, 2016 | -10.97M |
| September 30, 2016 | -7.898M |
| June 30, 2016 | -9.034M |
| March 31, 2016 | -5.05M |
| December 31, 2015 | -13.41M |
| September 30, 2015 | -20.15M |
| June 30, 2015 | -18.63M |
| March 31, 2015 | -11.96M |
| December 31, 2014 | 4.537M |
| September 30, 2014 | -12.66M |
| June 30, 2014 | -5.725M |
| March 31, 2014 | -4.748M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Quarterly) Benchmarks
| Spectral Medical, Inc. | 0.331M |
| Resverlogix Corp. | -8.421M |
| Theratechnologies, Inc. | -6.276M |
| Restart Life Sciences Corp. | -1.017M |
| Covalon Technologies Ltd. | 2.811M |
Net Income (Quarterly) Related Metrics
| Revenue (Quarterly) | 4.351M |
| Total Expenses (Quarterly) | 4.631M |
| EPS Diluted (Quarterly) | -0.267 |
| Enterprise Value | 4.574M |
| Gross Profit Margin (Quarterly) | 55.27% |
| Profit Margin (Quarterly) | -6.43% |
| Earnings Yield | -69.86% |
| Normalized Earnings Yield | -73.67 |